SHP2 in tumor-associated macrophages prompted the progression of colorectal cancer via modulating STAT3/PI3K signaling induced PD-1-mediated CAR-T cell apoptosis
Jianfa Xu, Jingbo Chen, Xiaoyu Zhang, Zibo Zhang, Guiying Wang · 2025
Read SHP2 in tumor-associated macrophages prompted the progression of colorectal cancer via modulating STAT3/PI3K signaling induced PD-1-mediated CAR-T cell apoptosis by Jianfa Xu, Jingbo Chen, Xiaoyu Zhang, Zibo Zhang, Guiying Wang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12749163.txt.
Description
Jianfa Xu and co-authors study a protein called SHP2 in immune cells that gather in colorectal tumors, and its role in tumor growth, in a 2025 paper. They ask how this protein affects cancer cells and a cell therapy that uses engineered immune cells. Gene data, cell cultures, and mouse models are combined.
Cancer and macrophage cell lines were grown together, and protein levels across signaling paths were measured. Tests tracked cancer cell growth, movement, and invasion. A three-way culture added engineered T cells to see whether the protein drives their death through a known checkpoint path. The authors link SHP2 to signals that help the tumor advance and weaken cell therapy.
Catalog record
| CREATOR | Jianfa Xu, Jingbo Chen, Xiaoyu Zhang, Zibo Zhang, Guiying Wang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |